Reuters logo
BRIEF-Bristol-Myers Squibb says Health Canada approved Daklinza in combination with Sofosbuvir
May 24, 2016 / 11:31 AM / 2 years ago

BRIEF-Bristol-Myers Squibb says Health Canada approved Daklinza in combination with Sofosbuvir

May 24 (Reuters) - Bristol-myers Squibb Co

* Myers squibb announces health canada’s approval of daklinza in combination with sofosbuvir

* Says health canada’s approval of daklinza in treatment of chronic hepatitis c in adult patients Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below